Yuanning Guo

Dr. Yuanning Guo

Technion – Israel Institute of Technology, Haifa, Israel
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
XLXi Liu
Xi Liu
MZMin Zhang
Min Zhang
SYSongmin Ying
Songmin Ying
CZChong Zhang
Chong Zhang
RLRunhua Lin
Runhua Lin
MSMin Su
Min Su

11 April 2022 in Cells
Verified
Journal Article
Open access
PDF file
YGYuanning Guo
Yuanning Guo
Ziv GilZiv Gil
Ziv Gil
Although the pathogenic operations of cancer–nerve crosstalk (e.g., neuritogenesis, neoneurogensis, and perineural invasion—PNI) in the peripheral nervous system (PNS) during tumorigenesis, as well as the progression of all cancer types is continuing to emerge as an area of unique scientific interest and study, extensive, wide-ranging, and multidisciplinary investigations still remain fragmented and unsystematic. This is especially so in regard to the roles played by extracellular vesicles (EVs), which are lipid bilayer-enclosed nano- to microsized particles that carry multiple-function molecular cargos, facilitate intercellular communication in diverse processes. Accordingly, the biological significance of EVs has been greatly elevated in recent years, as there is strong evidence that they could contribute to important and possibly groundbreaking diagnostic and therapeutic innovations. This can be achieved and the pace of discoveries accelerated through cross-pollination from existing knowledge and studies regarding nervous system physiology and pathology, as well as thoroughgoing collaborations between oncologists, neurobiologists, pathologists, clinicians, and researchers. This article offers an overview of current and recent past investigations on the roles of EVs in cancer–nerve crosstalk, as well as in neural development, physiology, inflammation, injury, and regeneration in the PNS. By highlighting the mechanisms involved in physiological and noncancerous pathological cellular crosstalk, we provide hints that may inspire additional translational studies on cancer–nerve interplay.


9 March 2026 in Research
Verified
Journal Article
Open access
FSFanglin Shao
Fanglin Shao
JWJie Wang
Jie Wang
ALAiqing Li
Aiqing Li
RWRuicheng Wu
Ruicheng Wu
JCJiamin Chen
Jiamin Chen
DFDechao Feng
Dechao Feng
The nervous system has emerged as a critical regulator of tumor biology. Over the past 2 decades, accumulating evidence has given rise to the rapidly expanding field of cancer neuroscience, revealing that neural circuits actively shape tumor initiation, progression, metastasis, prognosis, and therapeutic response. While the nervous system comprises both central and peripheral components, increasing attention has focused on the peripheral nervous system (PNS) as a key mediator of tumor–host interactions within the tumor microenvironment (TME). Autonomic (sympathetic, parasympathetic, and enteric) and sensory neural pathways interact dynamically with tumor cells, immune cells, glial cells, and other stromal components, influencing tumor growth, invasion, metastasis, and immune regulation through diverse cellular and molecular mechanisms. In addition, environmental and patient pathophysiological factors—including environmental stress, psychological states, pain, microbiota, aging, metabolic status, and lifestyle behaviors—can further modulate nerve–cancer interactions and reshape the tumor ecosystem. In this review, we systematically organize PNS–cancer interactions within the TME across 3 integrative dimensions: pathological phenotypes, cellular components, and modes of communication, thereby providing a conceptual framework for understanding the mechanistic landscape of cancer neuroscience. This structured perspective highlights the diverse modalities of nerve–tumor communication, identifies key modulatory factors influencing these interactions, and discusses emerging therapeutic strategies targeting nerve–cancer signaling.

29 November 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
RYRuijing Yan
Ruijing Yan
YGYi Guo
Yi Guo
QGQingyun Gong
Qingyun Gong
MCMan Chen
Man Chen
YGYuanning Guo
Yuanning Guo
MSMin Su
Min Su